Home › Pagtatae
Pag-aaral pangklinika para sa Pagtatae na nagre-recruit sa U.S.
9 pag-aaral para sa Pagtatae ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07545759Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT04038619Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Nagre-recruitPhase 4
Edad 6 hanggang 12 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07285785Rash & Diarrhea Prophylaxis With Capivasertib
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07426822A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06801067Fecal Microbiota Transplantation for IBS
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Kababaihan · Na-update May 8, 2026 · NCT05776914Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06684470First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 49 · Lahat ng kasarian · Na-update Nob 19, 2025 · NCT07205926Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
Nagre-recruit
Edad 25 hanggang 75 · Lahat ng kasarian · Na-update Ene 29, 2025 · NCT05465629Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.